(b) A tender to procure Linezolid is being prepared. Linezolid is available off code in the meantime.
2. (i) and (ii) For year 1 (1st April 2015 to 31 March 2016) we are prioritising XDR-TB, pre-XDR-TB and MRD-TB with hearing impairment, renal impairment and those to be operated.
Because the main focus will be on XDR-TB, we have started rolling out at our 12 facilities responsible for treating XDR-TB which are:
The 12 facilities treat all XDR-TB patients in the country.
3. A costed plan to make the drugs available has been developed and budgeted for in the HIV Conditional Grant. The drugs will be made available to 3 000 patients in year 1 (1st April 2015 to 31 March 2016), and then gradually increase to 6 000 at the end of year 3.
END.